key: cord-0019840-avwt6fbo authors: Kopczynska, Maja; Unwin, Harry; Pugh, Richard J.; Sharif, Ben; Chandy, Thomas; Davies, Daniel J.; Shield, Matthew E.; Purchase, David E.; Tilley, Samuel C.; Poacher, Arwel; Oliva, Lewis; Willis, Sam; Ray, Isabelle E.; Hui, John Ng C.; Payne, Bethany C.; Wardle, Eilis F.; Andrew, Fiona; Chan, Hei Man Priscilla; Barrington, Jack; Hale, Jay; Hawkins, Joanna; Nicholas, Jess K.; Wirt, Lara E.; Thomas, Lowri H.; Walker, Megan; Pan, Myat P.; Ray, Tallulah; Asim, Umair H.; Maidman, Victoria; Atiyah, Zeid; Nasser, Zain M.; Tan, Zhao Xuan; Tan, Laura J. P.; Szakmany, Tamas title: Four consecutive yearly point-prevalence studies in Wales indicate lack of improvement in sepsis care on the wards date: 2021-08-10 journal: Sci Rep DOI: 10.1038/s41598-021-95648-6 sha: 66c0ef8d908bef6223ea0b8021fcb70c9bd18ac1 doc_id: 19840 cord_uid: avwt6fbo The ‘Sepsis Six’ bundle was promoted as a deliverable tool outside of the critical care settings, but there is very little data available on the progress and change of sepsis care outside the critical care environment in the UK. Our aim was to compare the yearly prevalence, outcome and the Sepsis Six bundle compliance in patients at risk of mortality from sepsis in non-intensive care environments. Patients with a National Early Warning Score (NEWS) of 3 or above and suspected or proven infection were enrolled into four yearly 24-h point prevalence studies, carried out in fourteen hospitals across Wales from 2016 to 2019. We followed up patients to 30 days between 2016–2019 and to 90 days between 2017 and 2019. Out of the 26,947 patients screened 1651 fulfilled inclusion criteria and were recruited. The full ‘Sepsis Six’ care bundle was completed on 223 (14.0%) occasions, with no significant difference between the years. On 190 (11.5%) occasions none of the bundle elements were completed. There was no significant correlation between bundle element compliance, NEWS or year of study. One hundred and seventy (10.7%) patients were seen by critical care outreach; the ‘Sepsis Six’ bundle was completed significantly more often in this group (54/170, 32.0%) than for patients who were not reviewed by critical care outreach (168/1385, 11.6%; p < 0.0001). Overall survival to 30 days was 81.7% (1349/1651), with a mean survival time of 26.5 days (95% CI 26.1–26.9) with no difference between each year of study. 90-day survival for years 2017–2019 was 74.7% (949/1271), with no difference between the years. In multivariate regression we identified older age, heart failure, recent chemotherapy, higher frailty score and do not attempt cardiopulmonary resuscitation orders as significantly associated with increased 30-day mortality. Our data suggests that despite efforts to increase sepsis awareness within the NHS, there is poor compliance with the sepsis care bundles and no change in the high mortality over the study period. Further research is needed to determine which time-sensitive ward-based interventions can reduce mortality in patients with sepsis and how can these results be embedded to routine clinical practice. Trial registration Defining Sepsis on the Wards ISRCTN 86502304 https://doi.org/10.1186/ISRCTN86502304 prospectively registered 09/05/2016. Sepsis is defined as dysregulated host response to infection with sequential organ failure. It is a complex disorder and is associated with high mortality 1 . Despite increased awareness, sepsis remains a major challenge and economic burden to healthcare globally [2] [3] [4] [5] . To improve patient mortality, sepsis requires early recognition and urgent treatment 6 . Previously much attention was dedicated to the identification and treatment of patients at risk of poor outcomes within intensive care units (ICU) 7, 8 . However, it is now known that the majority of patients with sepsis present in the emergency department (ED) and on general wards, with associated high mortality [9] [10] [11] . Since the inception of the sepsis resuscitation bundle by the Surviving Sepsis Campaign (SSC) over a decade ago, completion rates have been reportedly low [12] [13] [14] . As the initial SSC bundle was heavily reliant on complex interventions, typically performed in a critical care environment, the 'Sepsis Six' bundle was promoted as a more deliverable tool outside of the critical care settings 15 . Although high-profile cases and systematic campaign from advocacy groups helped to increase awareness of the condition in the last decade, there is very little data available on the progress and change of sepsis care outside the critical care environment in the UK 15, 16 . While the use of sepsis screening tools and the delivery of the 'Sepsis Six' bundle is now a key performance indicator in many institutions, external scrutiny of such initiatives is lacking 17, 18 . The aim of our study was to examine the changes in care processes and outcomes over a four-year period, by utilising our yearly All Wales point-prevalence study on sepsis. Study design and participants. We performed a secondary analysis on the patient populations recruited into four annual multi-centre 24-h point-prevalence studies conducted on the third Wednesday of October from 2016 to 2019. The study was conducted accordance with relevant guidelines and regulations including the Declaration of Helsinki. The Defining Sepsis on the Wards project was prospectively registered with an international trial registry (ISRCTN86502304). Patients were recruited from each of the 14 acute hospitals across Wales, all of which had 24-h consultant cover in the ED and non-selective intake. Participating hospitals were identified through local collaborators via the Welsh Intensive Care Society Audit and Research Group. We screened all patients presenting to the ED and on the general wards. At the start of the study days at 08:00, data collectors systematically screened every patient on the acute in-patient wards within 4 h, then continued screening for any potential new participants until 07:59 the next morning. In each hospitals dedicated data collectors were stationed in the ED during the 24 h periods. We approached all patients with NEWS ≥ 3 in whom the treating clinical teams had a high degree of clinical suspicion of an infection (documented as such in the medical or nursing notes), and following the patients or their proxy, in cases of patients lacking capacity, gave written informed consent and were recruited to the study. Patients under 18 and those cared for in critical care or mental health units were excluded. Local investigators were identified and were supported by three national coordinators. Key study information was provided through e-mails, face-to-face training and online video tutorials, which included the protocol, answers to key questions and description of the electronic case report form (eCRF). The details of the digital data collection platform developed for this study have been published previously 19 . Medical students working in pairs to ensure data validity and appropriate clinical knowledge, acted as data collectors, using tablets for electronic data collection and transfer. The tablets contained all supporting information needed for the study, including national formulary. Data collectors were supported by continuous online web-chat, which made the senior clinicians and the medical student national coordinators available throughout the study period. We referred patients to the clinical teams if the medical student data collectors felt they needed urgent medical attention due to their condition, in line with the requirements of the ethics approval. To facilitate linkage to national databases for the collection of follow-up data, we collected patient-identifiable data and entered it on to the secure data collection tool 19 . Further description of the methodology and performance of this platform is outlined in previous publications 16, [18] [19] [20] [21] [22] [23] . We collected data from medical and nursing records on pre-admission patient characteristics, co-morbidities, physiological and laboratory values, Dalhousie clinical frailty score, and management actions such as the completion of the 'Sepsis Six' bundle and involvement of critical care outreach. In 2016, we conducted follow-up data collection for our primary outcome of all-cause mortality at 30 days from enrolment. In subsequent years (2017-2019) we conducted follow-up at 30 and 90 days. Policy content: During the study period all of the participating hospitals were actively engaged in the Rapid Response to Acute Illness Learning Set (RRAILS) programme led by 1000 Lives Improvement. In 2013, all hospitals in Wales implemented the use of NEWS, with a score of six or above set to trigger the escalation of patients to senior decision makers or for consideration of referral to critical care outreach. RRAILS promoted the use of standardised sepsis screening tool across the hospital since 2008 (see Supplementary Figure 1 ). In 2018 the Welsh Government introduced a quality improvement performance indicator for the completion of 'Sepsis Six' in all acute hospitals based on the RRAILS tool. Statistical analysis. Categorical www.nature.com/scientificreports/ ing. The starting point for the survival analysis was the data collection day. We estimated the respective hazard ratios (HRs) for the primary outcome within 30 days with a Cox proportional hazards model after adjustment for measured confounders. The model fit was assessed by the − 2 log likelihood statistics and Chi-square test. To increase sample size and to enable the inclusion of patients from all four study years, the primary analysis was performed on 30-day follow up results only. However, we also performed a subgroup analysis using the 90-day survival data using the results from the 2017 to 2019 studies. A two-tailed p-value < 0.05 was considered statistically significant. All statistical tests were calculated using SPSS 25.0 (SPSS Inc., Chicago, IL). Data visualisation was performed in R (Version 1.2.1335) with packages: ggplot2 (v3.3.3), dplyr (v1.0.5), UpSetR (v1.4.0), ComplexHeatmap (v2.7.8.1000) and sunburstR (v2.1.5), utilising repositories from Github (hms-dbmi/UpSetR, jokergoo/ComplexHeatmap and timelyportfolio/sunburstR) 24,25 . Ethical approval and consent to participate. Ethical approval was granted by the South Wales Regional Ethics Committee (16/WA/0071, 15/04/2016) and patients or legal representatives gave written informed consent. Patient characteristics. Over the four annual 24-h point-prevalence study periods, we screened a total of 26,947 patients, of whom 1651 met inclusion criteria and were subsequently recruited ( Fig. 1) . Patient demographics and clinical characteristics for each year of study are shown in Table 1 . The median age (IQR [range]) of participants was 73 years (60-82 ) and more females 852 (51.6%) than males 799 (48.4%) were recruited. The median (IQR) frailty score was 5 (3) (4) (5) (6) . Age, gender, and frailty of participants did not vary between years (Table 1 ). Overall, 289 (18.2%) patients were screened for sepsis using the ' All Wales sepsis screening tool' . The 'Sepsis Six' bundle was completed on 223 (14.0%) occasions. There were no significant trends in completion rates of the screening tools between 2016 and 2019, nor in the proportion of patients seen by critical care outreach ( Table 2) . The completion of overall, as well as individual elements of the 'Sepsis Six' bundle over time is further presented in Fig. 2 . When examined individual bundle elements, lactate measurement and obtaining blood cultures improved over time; however all elements were completed well below 70% of occasions (Fig. 2) . We found no differences between organisations in completing 'Sepsis Six' bundles (as displayed in Supplementary Figure 2) . Regardless of the number of bundle elements completed, we did not find any difference in the mortality across the years (Supplementary Figure 3) . No discernible trends or patterns were identified when we examined the completion of individual and combined bundle elements ( www.nature.com/scientificreports/ Blood cultures were obtained from 632 (46.0%) patients, of which 89 (14.1%) were positive for growth. Sputum sampling had a substantially higher positivity rate (35.9%). Other microbiology samples were infrequently collected (Table 3) . Antimicrobials were administered to 743 (64.3%) patients. Piperacillin-tazobactam, followed by co-amoxiclav and clarithromycin were the commonly used antibiotics used over the four-year period and are illustrated in Supplementary Figure 7 . One hundred and seventy (10.7%) patients were seen by critical care outreach; the 'Sepsis Six' bundle was completed significantly more often in this group (54/170, 32.0%) than for patients who were not reviewed by critical care outreach (168/1385, 11.6%; p < 0.0001). However, when plotted as a patient pathway these effects became less pronounced (illustrated in the river-plot in Supplementary Figure 8) . In planned sensitivity analysis we found that the percentage number of patients with NEWS 6 or above (overall n = 486, 29.4%) did not change significantly over the study period (Table 1 ). In this group, more patients had a ceiling of care (such as ward level care only or not for intubation decision) and also DNA-CPR orders in place (19.7% vs 9.5%, p < 0.0001 and 37.8% vs 21.2%, p < 0.0001, respectively) compared to the less acutely unwell population. The completion of the 'Sepsis Six' bundle was significantly higher for patients with NEWS 6 or above www.nature.com/scientificreports/ www.nature.com/scientificreports/ (20.9% vs 11.1%, p < 0.0001) but unchanged over the study period, as was the completion rate for individual bundle elements (shown in Supplementary Figure 9 ). Fig. 4 ). We observed significantly higher mortality in patients with NEWS 6 or above (23.5% vs 16.1%, p < 0.0001). Overall 90-day survival for years 2017 -2019 was 74.7% (949/1271). There was no difference in patient survival at 90 days between each year (see Kaplan-Meier curve in Supplementary Figure 10 ). On multivariate regression analysis, we identified older age, heart failure, recent chemotherapy, higher frailty score and do not attempt cardiopulmonary resuscitation (DNA-CPR) orders as significantly associated with increased mortality in patients with sepsis (Table 4 ). We identified that sepsis management in Wales (according to sepsis screening tool application and 'Sepsis Six' bundle compliance) has not altered over the four-year study period and that mortality remain largely unchanged. We found the demographic of the study population remained the same for each year, consisting of predominately frail and elderly patients with significant comorbidities. Approximately a third of the patients had a high NEWS and this group had higher likelihood of care limitations and DNA-CPR orders in place. Over the study period, there was no change in the short or medium-term mortality in the cohort, with approximately three out of four patients alive at 90 days. Our data opposes beliefs expressed that within the last decade the implementation of resuscitation bundles has led to better recognition of sepsis, in turn increasing the reported incidence of sepsis and reducing its apparent mortality 6, 26, 27 . Our observations are supported by recent analysis of studies identifying sepsis using direct clinical indicators of infection and organ dysfunction, suggesting that over the last decade the incidence and mortality of sepsis has in fact remained stable 28, 29 . Our findings that older age and higher frailty score are both associated with increased risk of mortality from sepsis, within an elderly population with high comorbidity burden, emphasise the threat of sepsis to patients www.nature.com/scientificreports/ throughout our hospitals 3,30-32 . The observations that heart failure and previous chemotherapy are associated with higher mortality from sepsis, are not new and are supported by results from large international cohorts 11, 33, 34 . 'Sepsis Six' bundle completion remained low with a mean of 14.0% over four years. The lack of improvement in completion of bundles probably underlines the significant problem of sepsis recognition outside of the ICU 35 . Our results support previously published UK and international data and highlight a significant concern in the real-world operationalising of response, which show significantly lower compliance in comparison to the sepsis performance measure (SEP-1) initiative or the resuscitation bundle promoted by the SCC 13, 36 . Alarmingly, only one in five patients received the full bundle in a group with higher risk of deterioration, i.e. NEWS 6 or above, whilst only one out of ten patients received the full bundle in the lower acuity group, with no change over the four years. However, we found that patients who were reviewed by critical care outreach were more often treated with the full 'Sepsis Six' bundle and had antibiotics administered. This result is in line with previous experiences, where introduction of a dedicated team has improved compliance with the bundle 37 . Whilst our study did not find any association between critical care outreach involvement and mortality, it is possible that illness severity is a confounding factor here. It's important to note that critical care outreach provision was variable across Wales during the study period 38 . Not every organisation had these services available and none of the hospitals had 24/7 critical care outreach on site. Furthermore, the existing critical care outreach services were nurse-led and delivered and at the time of the study, they did not have appropriate privileges for drug prescription and in some cases ordering tests either. Taking this into account, the associated three-fold increase in the 'Sepsis Six' bundle completion is remarkable. Our results point towards system failure to respond to sepsis as a medical emergency and highlight the need for policy change in the Welsh NHS in response to sepsis. Despite the introduction of the quality improvement target for 'Sepsis Six' bundle completion in 2017/2018 by the Welsh Government, we have seen little change across the study years 17 . This quality improvement target was not accompanied by financial incentives or any additional funding. Importantly, there is no publicly available report about the baseline measured by this methodology and any potential improvement attained since 2017/2018 in the Welsh NHS organisations. The implementation of care bundles have been shown to have significant institutional barriers, which may not be overcome by traditional plan-do-study-act quality improvement cycles 39, 40 . Importantly, neither the 'Sepsis Six' bundle, nor the SEP-1 bundle has been tested in a robust randomised controlled trial (RCT) and their perceived effectiveness has been derived from observational before and after studies with high risk of bias 41 . We believe, based on the individual bundle element compliance figures, that our data may show the presence of clinical equipoise for an RCT to test whether a bundle approach indeed improves outcomes compared to the current apparent standard care of administering supplemental oxygen and antibiotics to the majority of the patients with NEWS above 6. RECOVERY and REMAP-CAP have demonstrated the potential efficiency and effectiveness of adaptive platform trials [42] [43] [44] , and the recently funded Sepsis Trials in Critical Care (SEPTIC) platform (NIHR 17/136/02) illustrates such an approach in sepsis management. Adaptive platform trials create opportunities for 'learning health care systems' which promote efficient knowledge generation and transfer, use simple and purposeful data systems www.nature.com/scientificreports/ with transparent quality metrics, and integrate these into clinical, academic and commissioning structures [45] [46] [47] . Considering the significant evidence gap in the ward based sepsis care demonstrated in our study, we propose that a similar platform trial is necessary to delineate which timely, ward-based interventions can reduce mortality in patients with sepsis at the highest risk of adverse outcomes 46,48 . There are certain limitations to our study. Firstly, the dataset was designed to enable a sufficiently comprehensive list of clinical and laboratory parameters while being small enough to maintain data reliability. Data collection was performed by medical students at different stages of training, introducing potential bias. To counter this, robust online and in-person training was cascaded, and we ensured that medical student hospital leads in subsequent years had participated as data collectors 16, 20, 21 . We also maintained the core clinical leadership of the group throughout the study. Secondly, we have only collected longer-term outcome data and cause of death on a subset of patients and our long-term follow-up data is yet to be linked with the Welsh Secure Anonymous Information Linkage (SAIL) databank 31, 49 . The true human cost of sepsis in terms of re-hospitalisation and patient reported outcomes cannot be estimated from our results. Thirdly, although one of the largest in-depth sepsis studies in the UK, the sample-size is relatively small. However, we could not see any differences in sepsis incidence or outcomes based on geographical area, hospital status or size and we ensured that all acute hospitals in Wales participated in each year of the study 16, 20, 21 . Lastly, the point-prevalence design might have led to a systematic underestimate of compliance with 'Sepsis Six' completion; however, despite being mandated in the NHS Wales Delivery Framework in 2017 17 , there is no publicly available data generated by Welsh Health Boards to provide a comparison on longer-term longitudinal changes of this quality improvement index. Moreover, engagement of participating hospitals with our point-prevalence study has remained high and our results have been consistent across the study period. In summary, our data suggests that despite efforts to increase sepsis awareness within the NHS, there is poor compliance with the sepsis care bundles and there has been no change in outcomes over the study period. Our results highlight the ongoing need for clinical trials to determine which time-sensitive ward-based interventions are most likely to reduce mortality in patients with highest risk of death and which should be adopted by learning healthcare systems. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Recognizing sepsis as a global health priority-A WHO resolution Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations Sepsis among medicare beneficiaries: 1. The burdens of sepsis Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study Sepsis among medicare beneficiaries: 3. The methods, models, and forecasts of sepsis Time to treatment and mortality during mandated emergency care for sepsis Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis The third international consensus definitions for sepsis and septic shock (sepsis-3) Sepsis outside intensive care unit: The other side of the coin Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward Sepsis Among medicare beneficiaries: 2. The trajectories of sepsis Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock Association of a care bundle for early sepsis management with mortality among patients with hospital-onset or community-onset sepsis The surviving sepsis campaign bundles and outcome: Results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) The sepsis six and the severe sepsis resuscitation bundle: A prospective observational cohort study Defining sepsis on the wards: Results of a multi-centre point-prevalence study comparing two sepsis definitions A Snapshot of compliance with the sepsis six care bundle in two acute hospitals in the West Midlands Developing a digital data collection platform to measure the prevalence of sepsis in Wales Red-flag sepsis and SOFA identifies different patient population at risk of sepsis-related deaths on the general ward Real world patterns of antimicrobial use and microbiology investigations in patients with sepsis outside the critical care unit: Secondary analysis of three nation-wide point prevalence studies Insertion rates and complications of central lines in the UK population: A pilot study Prevalence and outcomes of acute hypoxaemic respiratory failure in wales: The PANDORA-WALES study R: A Language and Environment for Statistical Computing. R Foudnationf for Statistical Computing Elegant Graphics for Data Analysis Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: A prospective cohort study Multicenter implementation of a severe sepsis and septic shock treatment bundle Centers for disease control and prevention epicenters program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data Incidence and trends of sepsis in US hospitals using clinical vs claims data Prevalence, underlying causes, and preventability of sepsis-associated mortality in us acute care hospitals Sepsis-related deaths in the at-risk population on the wards: Attributable fraction of mortality in a large point-prevalence study Frailty assessed by administrative tools and mortality in patients with pneumonia admitted to the hospital and ICU in Wales The effect of age on the development and outcome of adult sepsis Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study Recognizing and managing sepsis: What needs to be done? Three-hour bundle compliance and outcomes in patients with undiagnosed severe sepsis Improving outcome of sepsis on the ward: Introducing the "Sepsis Six" bundle Identification of factors that support successful implementation of care bundles in the acute medical setting: A qualitative study Use of a single parameter track and trigger chart and the perceived barriers and facilitators to escalation of a deteriorating ward patient: A mixed methods study Driving blind: Instituting SEP-1 without high quality outcomes data Adaptive platform trials: Definition, design, conduct and reporting considerations Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system-Lessons learned and recommendations RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials Dexamethasone in hospitalized patients with covid-19 Why do we need some large, simple randomized trials? Interleukin-6 receptor antagonists in critically Ill patients with covid-19 What allows a health care system to become a learning health care system: Results from interviews with health system leaders The SAIL databank: Linking multiple health and social care datasets 18 Princess of Wales Hospital, Cwm Taf Morgannwg University Health Board, Bridgend, UK. 19 Royal Glamorgan Hospital The Authors would like to acknowledge the help of the Critical Care Outreach teams of the participating hospitals. The full list of collaborators is provided under the Welsh Digital Data Collection Platform Collaborators. The authors declare no competing interests. Supplementary Information The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-95648-6.